マルヤマ タクミ
Maruyama Takumi
丸山 拓実 所属 その他 その他 職種 薬剤師 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan. |
掲載誌名 | 正式名:International journal of environmental research and public health 略 称:Int J Environ Res Public Health ISSNコード:16604601/16604601 |
掲載区分 | 国外 |
巻・号・頁 | 19(5),pp.10.3390/ijerph19052516 |
著者・共著者 | Ebihara Fumiya, Hamada Yukihiro, Kato Hideo, Maruyama Takumi, Kimura Toshimi |
発行年月 | 2022/02 |
概要 | Under the Japanese health insurance system, medicines undergoing therapeutic drug monitoring (TDM) can be billed for medical fees if they meet the specified requirements. In Japan, TDM of vancomycin, teicoplanin, aminoglycosides, and voriconazole, which are used for the treatment of infectious diseases, is common practice. This means the levels of antibiotics are measured in-house using chromatography or other methods. In some facilities, the blood and/or tissue concentrations of other non-TDM drugs are measured by HPLC and are applied to treatment, which is necessary for personalized medicine. This review describes personalized medicine based on the use of chromatography as a result of the current situation in Japan. |
DOI | 10.3390/ijerph19052516 |
PMID | 35270215 |